Catalio Capital Management, LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$538.3M2026 Q3
Positions47
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.48.4%

Catalio Capital Management, LP reported 47 positions worth $538.3M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: AVLN (9.0%).

10 / 47 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 AVLNAvalyn Pharma$48.4M8.99%1,698,851——+4.5%
▸ 2 BMYBristol Myers Squibb$31.2M5.79%499,716——+0.8%
▸ 3 BBIOBridgeBio Pharma$28.0M5.20%425,111——+17.6%
▸ 4 PBLSParabilis Medicines$26.6M4.94%824,043——-13.8%
▸ 5 JNJJohnson & Johnson$26.3M4.89%99,496——+6.7%
▸ 6 ASNDAscendis Pharma A/S$23.1M4.29%101,445——+20.9%
▸ 7 ARWRArrowhead Pharmaceuticals$20.6M3.83%315,247——-32.5%
▸ 8 SNDXSyndax Pharmaceuticals$19.2M3.58%1,023,510——-49.7%
▸ 9 DFTXDefinium Therapeutics$19.0M3.52%497,964——-20.8%
▸ 10 CELCCelcuity$18.3M3.41%230,609——-23.8%

Pro Feature

The remaining 37 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Catalio Capital Management, LP hold as of Q3 2026?

Catalio Capital Management, LP reported 47 positions worth $538.3M in its Q3 2026 13F filing. Largest positions: AVLN (9.0%), BMY (5.8%), BBIO (5.2%), PBLS (4.9%) and JNJ (4.9%).

What did Catalio Capital Management, LP buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Catalio Capital Management, LP sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.